approval
saveICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
October 10, 2025updated 5mo ago
community read0 votes
Sponsor: TAKEDA PHARMS USA. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 5
- grantUNIVERSITY OF TX MD ANDERSON CAN CTR — Project Title: Low-dose erlotinib and mesalamine for prevention of colitis-as...Sep 25, 2025
- approvalVYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approvalSep 23, 2025
- approvalADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approvalSep 23, 2025
- approvalVYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approvalSep 23, 2025
- approvalLIVTENCITY (MARIBAVIR) — FDA approvalNov 21, 2025
comments(0)
5-min edit window · permanent after that